Previous meta-analysis has showed that GLP-1 RAs and SGLT-2 inhibitors may have different effects on each component of three-point MACE, which comprised cardiovascular death, myocardial infarction, and stroke29. This evidence concerns the gene SLC5A2 and myocardial infarction.